ATE354600T1 - Polyhydroxyalkanoate für in vivo anwendungen - Google Patents

Polyhydroxyalkanoate für in vivo anwendungen

Info

Publication number
ATE354600T1
ATE354600T1 AT98922281T AT98922281T ATE354600T1 AT E354600 T1 ATE354600 T1 AT E354600T1 AT 98922281 T AT98922281 T AT 98922281T AT 98922281 T AT98922281 T AT 98922281T AT E354600 T1 ATE354600 T1 AT E354600T1
Authority
AT
Austria
Prior art keywords
phas
polymers
tissue
bone
polyhydroxyalkanoates
Prior art date
Application number
AT98922281T
Other languages
English (en)
Inventor
Simon F Williams
David P Martin
Tillman Gerngross
Daniel M Horowitz
Original Assignee
Metabolix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolix Inc filed Critical Metabolix Inc
Application granted granted Critical
Publication of ATE354600T1 publication Critical patent/ATE354600T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C12P7/625—Polyesters of hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B42/00—Surgical gloves; Finger-stalls specially adapted for surgery; Devices for handling or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04—Macromolecular materials
    • A61L29/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/685—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
    • C08G63/6852—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/688—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur
    • C08G63/6882—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166—Sutures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article
AT98922281T 1997-05-12 1998-05-12 Polyhydroxyalkanoate für in vivo anwendungen ATE354600T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4621197P 1997-05-12 1997-05-12
US5428997P 1997-07-31 1997-07-31
US6350197P 1997-10-24 1997-10-24
US6592197P 1997-11-17 1997-11-17

Publications (1)

Publication Number Publication Date
ATE354600T1 true ATE354600T1 (de) 2007-03-15

Family

ID=27489042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98922281T ATE354600T1 (de) 1997-05-12 1998-05-12 Polyhydroxyalkanoate für in vivo anwendungen

Country Status (9)

Country Link
US (6) US6245537B1 (de)
EP (1) EP0981381B1 (de)
AT (1) ATE354600T1 (de)
AU (1) AU7486798A (de)
DE (1) DE69837141T2 (de)
DK (1) DK0981381T3 (de)
ES (1) ES2285770T3 (de)
PT (1) PT981381E (de)
WO (1) WO1998051812A2 (de)

Families Citing this family (226)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
PT981381E (pt) * 1997-05-12 2007-04-30 Metabolix Inc Poli-hidroxialcanoatos para aplicações in vivo
US6867248B1 (en) 1997-05-12 2005-03-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6610764B1 (en) 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6828357B1 (en) * 1997-07-31 2004-12-07 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
PT1042388E (pt) * 1997-12-22 2007-01-31 Metabolix Inc Composições de poli-hidroxialcanoato com velocidades de degradação controladas
US20030040790A1 (en) * 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US7967855B2 (en) 1998-07-27 2011-06-28 Icon Interventional Systems, Inc. Coated medical device
US8070796B2 (en) 1998-07-27 2011-12-06 Icon Interventional Systems, Inc. Thrombosis inhibiting graft
DE69931800T2 (de) * 1998-10-28 2007-07-12 Cellon S.A. Strukturierter und poröser silikonkautschuk
AU2004242432B2 (en) * 1999-03-04 2007-07-05 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
WO2000051662A1 (en) * 1999-03-04 2000-09-08 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
EP1878451A1 (de) * 1999-03-04 2008-01-16 Tepha, Inc. Bioabsorbierbare und biokompatible Polymere zur Gewebeverarbeitung
US6548569B1 (en) * 1999-03-25 2003-04-15 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
EP1212046A2 (de) 1999-08-30 2002-06-12 Tepha, Inc. Spülbare und wegwerfbare polymerprodukte
JP2003509128A (ja) * 1999-09-14 2003-03-11 テファ， インコーポレイテッド 軟部組織の修復、増強および粘性補充のためのポリヒドロキシアルカノエート組成物
US7025980B1 (en) 1999-09-14 2006-04-11 Tepha, Inc. Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation
US20030208279A1 (en) * 2001-04-30 2003-11-06 Anthony Atala Tissue engineered stents
ATE310472T1 (de) * 2000-04-28 2005-12-15 Childrens Medical Center Aus gewebe aufgebauter stent
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US7419678B2 (en) * 2000-05-12 2008-09-02 Cordis Corporation Coated medical devices for the prevention and treatment of vascular disease
MXPA03002871A (es) 2000-09-29 2004-12-06 Johnson & Johnson Dispositivos medicos recubiertos.
WO2002062969A2 (en) * 2001-02-06 2002-08-15 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
DE10122128A1 (de) * 2001-04-27 2002-11-07 Inst Polymerforschung Dresden Resorbierbares Patch-Implantat, Verfahren zu seiner Herstellung und Verwendung
JP2003015168A (ja) * 2001-04-27 2003-01-15 Canon Inc 電気泳動粒子、電気泳動粒子の製造方法、および電気泳動表示素子
US6787179B2 (en) * 2001-06-29 2004-09-07 Ethicon, Inc. Sterilization of bioactive coatings
JP3990880B2 (ja) * 2001-07-10 2007-10-17 キヤノン株式会社 ポリヒドロキシアルカノエート被覆リポソームの製造方法
AU2002356530A1 (en) * 2001-09-28 2003-04-07 Boston Scientific Limited Medical devices comprising nanomaterials and therapeutic methods utilizing the same
US8178128B2 (en) * 2001-12-05 2012-05-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Nanoparticles containing polymeric nucleic acid homologs
US7318833B2 (en) 2001-12-19 2008-01-15 Nmt Medical, Inc. PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
WO2003053493A2 (en) * 2001-12-19 2003-07-03 Nmt Medical, Inc. Septal occluder and associated methods
NL1019888C2 (nl) * 2002-02-01 2003-08-25 Univ Twente Werkwijze voor het vervaardigen van een poreuze polymeerstructuur.
DE10212553A1 (de) * 2002-03-16 2003-09-25 Knoell Hans Forschung Ev Verwendung einer Formulierung zur in situ Biodegradation von Wundabdeckungen
EP1487353A4 (de) 2002-03-25 2008-04-16 Nmt Medical Inc Klemmen zum verschluss eines patenten foramen ovale (pfo)
SE527054C2 (sv) * 2002-04-23 2005-12-13 Gambro Lundia Ab Förfarande för framställning av ett regioselektivt membran
FR2839260B1 (fr) * 2002-05-03 2005-02-25 Inst Nat Sante Rech Med Microparticules a base d'un materiau bicompatible et biodegradable, supportant des cellules et des substances biologiquement actives
US20050129776A1 (en) 2002-05-03 2005-06-16 Inserm Microparticles supporting cells and active substances
JP4780961B2 (ja) * 2002-05-10 2011-09-28 メタボリックス，インコーポレイテッド ２−ヒドロキシ酸モノマーを含む生体吸収性ポリマー
EP1538994A4 (de) 2002-06-05 2008-05-07 Nmt Medical Inc Vorrichtung zum verschliessen eines patenten foramen ovale (pfo) mit radialer und umfangsunterstützung
JP4638735B2 (ja) 2002-06-24 2011-02-23 タフツ ユニバーシティー 絹糸生体材料およびその使用方法
US8016881B2 (en) 2002-07-31 2011-09-13 Icon Interventional Systems, Inc. Sutures and surgical staples for anastamoses, wound closures, and surgical closures
KR100529209B1 (ko) * 2002-08-28 2005-11-17 한국과학기술연구원 세포 친화성이 향상된 생분해성의 조직 공학용 다공성고분자 지지체의 제조방법
WO2004028615A1 (ja) * 2002-09-25 2004-04-08 Kabushikikaisha Igaki Iryo Sekkei 脈管ステント用糸及びこの糸を用いた脈管用ステント
AU2003284976A1 (en) 2002-10-25 2004-05-13 Nmt Medical, Inc. Expandable sheath tubing
EP1562653A1 (de) * 2002-11-06 2005-08-17 NMT Medical, Inc. Medizinischevorrichtungen bestehend aus veränderten formgedächtnislegierungen
US7285287B2 (en) * 2002-11-14 2007-10-23 Synecor, Llc Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses
AU2003294682A1 (en) 2002-12-09 2004-06-30 Nmt Medical, Inc. Septal closure devices
JP4698596B2 (ja) 2003-04-10 2011-06-08 タフツ ユニバーシティー 濃縮された水性シルクフィブロイン溶液およびそれらの使用
JP2007525601A (ja) * 2003-05-08 2007-09-06 テファ， インコーポレイテッド ポリヒドロキシアルカノエート医療用織物および医療用繊維
EP1651273B1 (de) * 2003-07-08 2012-08-29 Tepha, Inc. Poly-4-hydroxybutyrat-matrizes zur kontinuierlichen arzneistoffzuführung
EP2481356B1 (de) 2003-07-14 2013-09-11 W.L. Gore & Associates, Inc. Rohrförmige Verschlussvorrichtung mit Sperrsystem für persistierendes Foramen ovale (PFO)
US9861346B2 (en) * 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
CA2536368A1 (en) 2003-08-19 2005-03-03 Nmt Medical, Inc. Expandable sheath tubing
JP2007503221A (ja) * 2003-08-22 2007-02-22 テファ， インコーポレイテッド ポリヒドロキシアルカノエート神経再生デバイス
US20050273119A1 (en) 2003-12-09 2005-12-08 Nmt Medical, Inc. Double spiral patent foramen ovale closure clamp
WO2005065396A2 (en) 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
US7211108B2 (en) * 2004-01-23 2007-05-01 Icon Medical Corp. Vascular grafts with amphiphilic block copolymer coatings
CA2558247A1 (en) 2004-03-03 2005-10-06 Nmt Medical, Inc. Delivery/recovery system for septal occluder
US20050267524A1 (en) 2004-04-09 2005-12-01 Nmt Medical, Inc. Split ends closure device
US8361110B2 (en) 2004-04-26 2013-01-29 W.L. Gore & Associates, Inc. Heart-shaped PFO closure device
US20060240065A1 (en) * 2005-04-26 2006-10-26 Yung-Ming Chen Compositions for medical devices containing agent combinations in controlled volumes
US8308760B2 (en) 2004-05-06 2012-11-13 W.L. Gore & Associates, Inc. Delivery systems and methods for PFO closure device with two anchors
US7842053B2 (en) 2004-05-06 2010-11-30 Nmt Medical, Inc. Double coil occluder
EP1748732A1 (de) 2004-05-07 2007-02-07 NMT Medical, Inc. Fangmechanismen für einen röhrenförmigen septumokkluder
TW200617171A (en) * 2004-06-29 2006-06-01 Procter & Gamble Improved process for the solvent-based extraction of polyhydroxyalkanoates from biomass
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
US7641825B2 (en) * 2004-08-03 2010-01-05 Tepha, Inc. Method of making a polyhydroxyalkanoate filament
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US7229471B2 (en) * 2004-09-10 2007-06-12 Advanced Cardiovascular Systems, Inc. Compositions containing fast-leaching plasticizers for improved performance of medical devices
WO2006036837A2 (en) 2004-09-24 2006-04-06 Nmt Medical, Inc. Occluder device double securement system for delivery/recovery of such occluder device
US20060095021A1 (en) * 2004-11-02 2006-05-04 Casas-Bejar Jesus W Introduction of agent with medical device
US10207095B2 (en) * 2004-12-14 2019-02-19 C. R. Bard, Inc. Fast clear port
ATE481088T1 (de) * 2005-01-28 2010-10-15 Tepha Inc Embolisierung unter verwendung von poly-4- hydroxybutyrat-partikeln
WO2006110197A2 (en) 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US20060200048A1 (en) * 2005-03-03 2006-09-07 Icon Medical Corp. Removable sheath for device protection
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
US8277480B2 (en) 2005-03-18 2012-10-02 W.L. Gore & Associates, Inc. Catch member for PFO occluder
WO2006124791A2 (en) * 2005-05-16 2006-11-23 Integra Lifesciences Corporation Pyrogen-free neurosurgical sponges
JP2009509530A (ja) * 2005-09-27 2009-03-12 ヘルムート アダム レフム，ベルン ポリマー粒子およびその使用
US8992965B2 (en) * 2005-11-01 2015-03-31 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
JP5457032B2 (ja) * 2005-11-04 2014-04-02 ピーピーディー メディテック 多孔質材料及びそれを製作する方法
US20070131610A1 (en) * 2005-12-13 2007-06-14 General Electric Company Membrane-based apparatus and associated method
US20070131611A1 (en) * 2005-12-13 2007-06-14 General Electric Company Membrane-based article and associated method
US7976891B1 (en) 2005-12-16 2011-07-12 Advanced Cardiovascular Systems, Inc. Abluminal stent coating apparatus and method of using focused acoustic energy
EP1962695A1 (de) 2005-12-22 2008-09-03 NMT Medical, Inc. Fangglieder für verschlussvorrichtungen
US9592325B2 (en) 2006-02-07 2017-03-14 Tepha, Inc. Polymeric, degradable drug-eluting stents and coatings
WO2007092464A2 (en) * 2006-02-07 2007-08-16 Tepha, Inc. Methods and devices for rotator cuff repair
US8979921B2 (en) 2006-02-07 2015-03-17 Tepha, Inc. Polymeric, degradable drug-eluting stents and coatings
JP5508720B2 (ja) 2006-02-07 2014-06-04 テファ， インコーポレイテッド 重合体分解性薬物溶出ステントおよび被膜
WO2007115125A2 (en) 2006-03-31 2007-10-11 Nmt Medical, Inc. Deformable flap catch mechanism for occluder device
US8870913B2 (en) 2006-03-31 2014-10-28 W.L. Gore & Associates, Inc. Catch system with locking cap for patent foramen ovale (PFO) occluder
US8551135B2 (en) 2006-03-31 2013-10-08 W.L. Gore & Associates, Inc. Screw catch mechanism for PFO occluder and method of use
US7775178B2 (en) * 2006-05-26 2010-08-17 Advanced Cardiovascular Systems, Inc. Stent coating apparatus and method
US9884142B2 (en) 2006-06-13 2018-02-06 Alchimedics Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating
US11039942B2 (en) 2006-06-13 2021-06-22 Sino Medical Sciences Technology Inc. Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers
US20070288088A1 (en) * 2006-06-13 2007-12-13 Christophe Bureau Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating
US20100028451A1 (en) 2006-09-26 2010-02-04 Trustees Of Tufts College Silk microspheres for encapsulation and controlled release
US9066996B1 (en) * 2006-10-13 2015-06-30 Hrl Laboratories, Llc Method to control the biodegradation rates of polymer structures
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
EP2269664B1 (de) 2007-01-21 2012-08-22 Hemoteq AG Medizinprodukt zur Behandlung von Verschlüssen von Körperdurchgängen und zur Prävention drohender Wiederverschlüsse
US20080188936A1 (en) * 2007-02-02 2008-08-07 Tornier, Inc. System and method for repairing tendons and ligaments
DE102007008479A1 (de) * 2007-02-21 2008-09-04 Orlowski, Michael, Dr. Beschichtetes Expandierbares System
US9102916B2 (en) 2007-02-27 2015-08-11 Trustees Of Tufts College Tissue-engineered silk organs
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
US9138562B2 (en) 2007-04-18 2015-09-22 W.L. Gore & Associates, Inc. Flexible catheter system
DE102007025452A1 (de) * 2007-05-31 2008-12-04 Ernst-Moritz-Arndt-Universität Greifswald Verfahren zur Beschichtung von Oberflächen mit Mikro- und Nanopartikeln mit Hilfe von Plasmaverfahren
EP2865404B1 (de) * 2007-06-01 2019-09-11 Covidien LP Verlängerungsröhren für ballonkatheter
WO2008157492A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
EP2167147B1 (de) 2007-06-15 2017-03-29 Warsaw Orthopedic, Inc. Knochenmatrixzusammensetzungen und verfahren
WO2008157497A2 (en) * 2007-06-15 2008-12-24 Osteotech, Inc. Method of treating tissue
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
US9358113B2 (en) * 2007-07-10 2016-06-07 Warsaw Orthopedic, Inc. Delivery system
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
US9808557B2 (en) 2007-08-10 2017-11-07 Trustees Of Tufts College Tubular silk compositions and methods of use thereof
DE102007000694B4 (de) * 2007-09-04 2009-06-10 Leibniz-Institut Für Polymerforschung Dresden E.V. Nukleierte Poly-3-Hydroxybuttersäure-Fäden und Verfahren zu ihrer Herstellung und Verwendung
EP2211921B1 (de) 2007-10-19 2013-12-25 Warsaw Orthopedic, Inc. Demineralisierte knochenmatrix-zusammensetzungen und verfahren
US20090112259A1 (en) * 2007-10-31 2009-04-30 Angiotech Pharmaceuticals, Inc. Recombinant expressed bioadsorbable polyhydroxyalkonate monofilament and multi-filaments self-retaining sutures
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
EP2231913B1 (de) * 2007-12-19 2013-01-23 Tepha, Inc. Medizinische vorrichtungen mit schmelzgeblasenen vliesstoffen aus poly-r-hydroxybutyrat und copolymeren
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
WO2009158724A2 (en) 2008-06-27 2009-12-30 Tepha, Inc. Improved injectable delivery of microparticles and compositions therefore
US7951193B2 (en) 2008-07-23 2011-05-31 Boston Scientific Scimed, Inc. Drug-eluting stent
WO2010093959A2 (en) * 2009-02-12 2010-08-19 Osteotech, Inc. Delivery systems, tools, and methods of use
US8956389B2 (en) 2009-06-22 2015-02-17 W. L. Gore & Associates, Inc. Sealing device and delivery system
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
EP3064230B1 (de) 2009-07-10 2019-04-10 Boston Scientific Scimed, Inc. Verwendung von nanokristallen für einen wirkstofffreisetzungsballon
JP5933434B2 (ja) 2009-07-17 2016-06-08 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 薬剤送達バルーンの製造方法
WO2011037658A1 (en) * 2009-09-25 2011-03-31 Tornier, Inc. Implantable patch and surgical kit for preparation thereof
WO2011068952A1 (en) 2009-12-02 2011-06-09 Entrigue Surgical, Inc. Devices for tongue stabilization
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
PT2558133T (pt) 2010-03-26 2020-04-23 Tepha Inc Revestimentos para o fabrico e aplicação de dispositivos médicos de polihidroxialcanqato
CA2802212C (en) 2010-06-15 2015-03-24 Tepha, Inc. Medical devices containing dry spun non-wovens of poly-4-hydroxybutyrate and copolymers
US9511169B2 (en) 2010-06-15 2016-12-06 Tepha, Inc. Medical devices containing dry spun non-wovens of poly-4-hydroxybutyrate and copolymers with anisotropic properties
EP2598552A1 (de) * 2010-07-28 2013-06-05 University Of Akron Biologisch abbaubare funktionspolymere
EP2425865A1 (de) 2010-08-06 2012-03-07 Aesculap AG Medizinisches Gewinde mit Polyhydroxyalkanoatbeschichtung
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US9162010B2 (en) 2010-11-09 2015-10-20 Tepha, Inc. Drug eluting cochlear implants
FR2968506B1 (fr) * 2010-12-14 2013-02-08 Ifremer Nucleus recouvert de pha
US9078634B2 (en) 2011-01-27 2015-07-14 Cryosa, Llc Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
US8920361B2 (en) * 2011-04-05 2014-12-30 The Texas A&M University System Plasma treatment and plasma enhanced chemical vapor deposition onto temperature sensitive biological materials
US10335519B2 (en) 2011-04-20 2019-07-02 Trustees Of Tufts College Dynamic silk coatings for implantable devices
ES2465570T3 (es) 2011-06-20 2014-06-06 Technische Universität Graz Materiales poliméricos híbridos para aplicaciones médicas y preparación de los mismos
WO2013022458A1 (en) 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
WO2013033209A1 (en) * 2011-08-29 2013-03-07 Novomer, Inc. Poly (hydroxy alkanoate) co-polymers
US8680228B2 (en) 2011-09-27 2014-03-25 Tepha, Inc. Controlled hydrolysis of poly-4-hydroxybutyrate and copolymers
US9554989B2 (en) 2012-03-20 2017-01-31 Trustees Of Tufts College Silk reservoirs for drug delivery
MX2014012208A (es) 2012-04-13 2015-05-08 Tufts College Metodo y composiciones para preparar una microesfera de seda.
ES2822000T3 (es) 2012-05-21 2021-04-28 Tepha Inc Composiciones biocerámicas reabsorbibles de poli-4-hidroxibutirato y copolímeros
WO2013181604A1 (en) 2012-05-31 2013-12-05 Micromidas, Inc. Polyhydroxyalkanoate derivatives, preparation and uses thereof
US10034945B2 (en) 2012-07-13 2018-07-31 Trustees Of Tufts College Silk powder compaction for production of constructs with high mechanical strength and stiffness
ES2774932T3 (es) 2012-11-14 2020-07-23 Cj Cheiljedang Corp Producción de sales de 4-hidroxibutirato utilizando materias primas de base biológica
EP2945655B1 (de) 2013-01-15 2019-09-25 Tepha, Inc. Implantate zur regeneration von weichem und hartem gewebe
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
US9290612B2 (en) 2013-03-13 2016-03-22 Tepha, Inc. Compositions and devices of poly-4-hydroxybutyrate
US10201640B2 (en) 2013-03-13 2019-02-12 Tepha, Inc. Ultrafine electrospun fibers of poly-4-hydroxybutyrate and copolymers thereof
US11376329B2 (en) 2013-03-15 2022-07-05 Trustees Of Tufts College Low molecular weight silk compositions and stabilizing silk compositions
EP3412682B1 (de) 2013-03-15 2022-08-31 Trustees Of Tufts College Niedermolekulare seidenzusammensetzungen und stabilisierende seidenzusammensetzungen
WO2014176458A2 (en) 2013-04-24 2014-10-30 Trustees Of Tufts College Bioresorbable biopolymer anastomosis devices
WO2014186435A2 (en) 2013-05-14 2014-11-20 University Of Georgia Research Foundation, Inc. Compositions and methods for reducing neointima formation
US10308972B2 (en) 2013-06-17 2019-06-04 Sanofi Chimie Whole-cell system for cytochrome P450 monooxygenases biocatalysis
ES2878122T3 (es) 2013-08-20 2021-11-18 Tepha Inc Espumas de celda cerrada que incluyen poli-4-hidroxibutirato y copolímeros del mismo
US9687585B2 (en) 2013-08-20 2017-06-27 Tepha, Inc. Thermoformed poly-4-hydroxybutyrate medical implants
US9302029B2 (en) 2013-10-31 2016-04-05 Tepha, Inc. Pultrusion of poly-4-hydroxybutyrate and copolymers thereof
WO2015069556A1 (en) 2013-11-05 2015-05-14 Tepha, Inc. Compositions and devices of poly-4-hydroxybutyrate
US10633625B2 (en) 2013-11-16 2020-04-28 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3082617B1 (de) 2013-12-19 2022-11-16 Tornier, Inc. Bioresorbierbare hochfeste naht
EP3086820B1 (de) 2013-12-26 2020-10-28 Tepha, Inc. Medizinische implantate mit laminaten aus poly-4-hydroxybutyrat und copolymeren davon
EP3119930B1 (de) 2014-03-18 2018-06-13 Tepha, Inc. Micro-faserbahnen von poly-4-hydroxybutyrat und copolymere davon durch zentrifugenspinnen hergestellt
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
US10335257B2 (en) 2014-04-30 2019-07-02 Tepha, Inc. Three-dimensional resorbable implants for tissue reinforcement and hernia repair
EP3142716B1 (de) 2014-05-16 2018-04-25 Tepha, Inc. Medizinische vorrichtungen mit trockengesponnenen vliesstoffen aus poly-4-hydroxybutyrat und copolymeren mit anisotropen eigenschaften
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US9381280B2 (en) 2014-06-13 2016-07-05 Abbott Cardiovascular Systems Inc. Plasticizers for a biodegradable scaffolding and methods of forming same
BR112016030273A2 (pt) 2014-06-24 2017-08-22 Icon Medical Corp Dispositivo médico e método para formar o referido dispositivo
EP3180040B1 (de) 2014-08-15 2020-05-13 Tepha, Inc. Selbsthaltendes chirurgisches nahtmaterial aus poly-4-hydroxybutyrat und copolymeren davon
WO2016028292A1 (en) 2014-08-20 2016-02-25 Tepha, Inc. Thermoformed poly-4-hydroxybutyrate medical implants
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
US11534335B2 (en) 2014-10-01 2022-12-27 Cryosa, Inc. Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
CA2969429C (en) 2014-12-11 2020-10-27 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10758645B2 (en) 2014-12-17 2020-09-01 Tufts University Injectable, flexible hydroxyapatite-silk foams for osteochondral and dental repair
WO2016160012A1 (en) 2015-04-01 2016-10-06 Yale University Iron platinum particles for adherence of biologics on medical implants
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
JP6811232B2 (ja) 2015-07-20 2021-01-13 タフツ・ユニバーシティ 生分解性シルク耳チューブ
US11766506B2 (en) 2016-03-04 2023-09-26 Mirus Llc Stent device for spinal fusion
US20180346943A1 (en) * 2016-03-25 2018-12-06 Kaneka Corporation Polyhydroxyalkanoic acid having functional group at terminal carboxy group and method for producing the same
US10864299B2 (en) 2016-04-29 2020-12-15 Trustees Of Tufts College Artificial silk based innervated cornea
EP3464565A4 (de) 2016-05-25 2020-01-01 Terumo BCT, Inc. Zellexpansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
WO2017221755A1 (ja) 2016-06-23 2017-12-28 株式会社カネカ ポリヒドロキシアルカン酸の製造方法
WO2018006037A1 (en) 2016-07-01 2018-01-04 Trustees Of Tufts College Innervated artificial skin
US11248313B2 (en) 2016-08-01 2022-02-15 Trustees Of Tufts College Biomimetic mechanical tension driven fabrication of nanofibrillar architecture
US10072120B2 (en) 2016-12-02 2018-09-11 International Business Machines Corporation Functionalized polyhydroxyalkanoate materials formed from an unsaturated polyhydroxyalkanoate material
US10081706B2 (en) 2017-01-03 2018-09-25 International Business Machines Corporation Side-chain-functionalized polyhydroxyalkanoate materials
US20200000713A1 (en) 2017-01-20 2020-01-02 Massachusetts Institute Of Technology Injectable polymer micro-depots for controlled local drug delivery
GB201702475D0 (en) * 2017-02-15 2017-03-29 Locate Therapeutics Ltd Tissue scaffold and scaffold composition
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CA3064729C (en) 2017-05-25 2022-03-29 Tepha, Inc. Continuous formation of tubes of poly-4-hydroxybutyrate and copolymers thereof
EP3678715A1 (de) 2017-09-06 2020-07-15 Tepha, Inc. Kalandrierte chirurgische netze mit polyhydroxyalkanoaten
WO2019089567A1 (en) 2017-10-30 2019-05-09 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
US20210236644A1 (en) 2017-11-10 2021-08-05 Cocoon Biotech Inc. Ocular applications of silk-based products
EP3720514B1 (de) 2017-12-04 2022-04-13 Tepha, Inc. Vakuummembran-thermogeformte medizinische poly-4-hydroxybutyrat-implantate
EP3802062A2 (de) 2018-06-11 2021-04-14 Tepha, Inc. Verfahren zum 3d-drucken von poly-4-hydroxybutyrat und copolymeren
WO2020092065A1 (en) 2018-10-29 2020-05-07 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
CA3142608A1 (en) 2019-06-04 2020-12-10 Cocoon Biotech Inc. Silk-based products, formulations, and methods of use
FR3109290A1 (fr) 2020-04-17 2021-10-22 Ph Tech Dispositif médical comprenant une matrice biologique acellulaire et au moins un polymère
FR3110077A1 (fr) 2020-05-12 2021-11-19 Ph Tech Procédé de fabrication d’un dispositif médical en trois dimensions et dispositif médical obtenu
FR3113371A1 (fr) 2020-08-12 2022-02-18 Ph Tech Dispositif médical comprenant un assemblage d’éléments de matrices biologiques acellulaires et au moins un polymère
CN116490222A (zh) 2020-10-26 2023-07-25 三菱瓦斯化学株式会社 生物可吸收性纤维状医疗材料
CN112552500B (zh) * 2021-01-04 2022-12-20 珠海麦得发生物科技股份有限公司 一种去除发酵法PHAs中内毒素的方法
CN113121807B (zh) * 2021-04-07 2022-05-06 珠海麦得发生物科技股份有限公司 一种去除发酵法PHAs中内毒素的方法
WO2023181762A1 (ja) * 2022-03-22 2023-09-28 株式会社カネカ ポリヒドロキシアルカン酸水性懸濁液及びその製造方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145233B2 (de) 1983-11-23 1991-11-06 Imperial Chemical Industries Plc Trennungsverfahrenfür ein 3-hydroxybutyrat-Polymer
US4648978A (en) 1985-04-24 1987-03-10 American Sterilizer Company Process for the continuous preparation of sterile, depyrogenated solutions
US4711241A (en) 1986-09-05 1987-12-08 American Cyanamid Company Surgical filament coating
US5032638A (en) * 1986-09-05 1991-07-16 American Cyanamid Company Bioabsorbable coating for a surgical device
NL8603073A (nl) 1986-12-02 1988-07-01 Rijksuniversiteit Werkwijze voor het bereiden van polyesters door fermentatie; werkwijze voor het bereiden van optisch actieve carbonzuren en esters; polyester omvattende voortbrengselen.
US5480794A (en) 1987-06-29 1996-01-02 Massachusetts Institute Of Technology And Metabolix, Inc. Overproduction and purification of soluble PHA synthase
US5245023A (en) 1987-06-29 1993-09-14 Massachusetts Institute Of Technology Method for producing novel polyester biopolymers
US5250430A (en) 1987-06-29 1993-10-05 Massachusetts Institute Of Technology Polyhydroxyalkanoate polymerase
US5229279A (en) 1987-06-29 1993-07-20 Massachusetts Institute Of Technology Method for producing novel polyester biopolymers
SE8802414D0 (sv) 1988-06-27 1988-06-28 Astra Meditec Ab Nytt kirurgiskt material
US5026381A (en) 1989-04-20 1991-06-25 Colla-Tec, Incorporated Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit
IT1247157B (it) 1991-02-11 1994-12-12 Fidia Spa Canali di guida biodegradabili e bioassorbibili da impiegare per la rigenerazione nervosa.
US5480394A (en) 1991-09-27 1996-01-02 Terumo Kabushiki Kaisha Flexible member for use as a medical bag
GB9307674D0 (en) 1993-04-14 1993-06-02 Zeneca Ltd Production of plastics materials from microorganisms
JP3243334B2 (ja) 1993-06-10 2002-01-07 テルモ株式会社 ヒドロキシアルカノエート重合体組成物
JPH07275344A (ja) 1994-04-05 1995-10-24 Nippon Zeon Co Ltd 軟組織用医療用材料
US5584885A (en) 1994-04-28 1996-12-17 Seckel; Brooke R. Nerve regeneration chamber
NL9401037A (nl) 1994-06-23 1996-02-01 Soonn Stichting Onderzoek En O Werkwijze voor het bereiden van een biologisch afbreekbare polyhydroxyalkanoaat coating met behulp van een waterige dispersie van polyhydroxyalkanoaat.
US5563239A (en) 1994-11-09 1996-10-08 Eastman Chemical Company Composition and process for the production of poly(3-hydroxyalkanoates)
US5688900A (en) * 1995-01-19 1997-11-18 Ethicon, Inc. Absorbable polyalkylene diglycolates
ATE179757T1 (de) * 1995-02-09 1999-05-15 Monsanto Co Polyhydroxyalkanoatelatex
US5723010A (en) * 1995-03-31 1998-03-03 Toyo Boseki Kabushiki Kaisha Medical device and method for producing the same
AU3406495A (en) 1995-08-14 1997-03-12 University Of Massachusetts Medical Center Methods of controlling microbial polyester structure
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
DE69837917T2 (de) 1997-04-21 2008-02-21 Metabolix, Inc., Cambridge Endstellige hydroxyl aufweisende polyhydroxyalkanoate
PT981381E (pt) 1997-05-12 2007-04-30 Metabolix Inc Poli-hidroxialcanoatos para aplicações in vivo
US6610764B1 (en) 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6420273B1 (en) * 1997-06-30 2002-07-16 Koninklijke Philips Electronics N.V. Self-aligned etch-stop layer formation for semiconductor devices
PT1042388E (pt) 1997-12-22 2007-01-31 Metabolix Inc Composições de poli-hidroxialcanoato com velocidades de degradação controladas
ATE458822T1 (de) 1998-04-08 2010-03-15 Metabolix Inc Verfahren für die trennung und reinigung von biopolymeren
US7025980B1 (en) 1999-09-14 2006-04-11 Tepha, Inc. Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation
JP2007165558A (ja) * 2005-12-13 2007-06-28 Matsushita Electric Ind Co Ltd 半導体装置およびその製造方法
US20070296052A1 (en) * 2006-06-26 2007-12-27 Taiwan Semiconductor Manufacturing Company, Ltd. Methods of forming silicide regions and resulting MOS devices

Also Published As

Publication number Publication date
US7244442B2 (en) 2007-07-17
DE69837141T2 (de) 2007-10-31
ES2285770T3 (es) 2007-11-16
DK0981381T3 (da) 2007-06-04
DE69837141D1 (de) 2007-04-05
US8771720B2 (en) 2014-07-08
PT981381E (pt) 2007-04-30
US20070280899A1 (en) 2007-12-06
US20040053381A1 (en) 2004-03-18
WO1998051812A3 (en) 1999-02-11
US7906135B2 (en) 2011-03-15
EP0981381B1 (de) 2007-02-21
AU7486798A (en) 1998-12-08
US20010009769A1 (en) 2001-07-26
US8231889B2 (en) 2012-07-31
WO1998051812A2 (en) 1998-11-19
US20110135707A1 (en) 2011-06-09
US6245537B1 (en) 2001-06-12
EP0981381A2 (de) 2000-03-01
US20120328523A1 (en) 2012-12-27
US6623749B2 (en) 2003-09-23

Similar Documents

Publication Publication Date Title
DE69837141D1 (de) Polyhydroxyalkanoate für in vivo anwendungen
BR9811000A (pt) "composições poliméricas"
Lee et al. Degradable and injectable poly (aldehyde guluronate) hydrogels for bone tissue engineering
Feng et al. Progress in depsipeptide‐based biomaterials
EP2598180B1 (de) Hydrogel auf hyaluronsäurebasis und seine verwendung in der chirurgie
Afghah et al. 3D printing of silver-doped polycaprolactone-poly (propylene succinate) composite scaffolds for skin tissue engineering
Kumbar et al. In vitro and in vivo characterization of biodegradable poly (organophosphazenes) for biomedical applications
NO982703L (no) Lineµre blokkpolymerer som omfatter urea- og uretangrupper, fremgangsmÕte til fremstilling av lineµre blokkpolymerer og anvendelse av blokkpolymerene som implantater
ATE235273T1 (de) Halbineinandergreifendes polymernetzwerk
HUP0001256A2 (hu) Biológiailag lebomló tereftalát-poliészter-polifoszfonát-polimerek, készítmények, eljárás előállításukra és alkalmazásuk
DE60108651D1 (de) Wärmegellierende bioabbaubare wässrige polymerlösung
ATE346878T1 (de) Elastomerische, funktionelle, bioabbaubare copolyesteramide und copolyesterurethane
EP0635531A3 (de) Flüssige Copolymere aus E-Caprolacton und Lactide
EA200700435A1 (ru) Рентгеноконтрастные полимерные стенты
Guadalupe et al. Bioactive polymeric nanofiber matrices for skin regeneration
DE59711402D1 (de) Injizierbare polymerzusammensetzung zur herstellung eines in-situ-implantats
CA2570410A1 (en) Radiographic contrasting agents and radio-opaque polymeric materials for medical devices
Osman et al. A sticky carbohydrate meets a mussel adhesive: Catechol-conjugated levan for hemostatic and wound healing applications
Foroughi et al. Physically crosslinked polyvinyl alcohol/chitosan/gum tragacanth hydrogels loaded with vitamin E for wound healing applications
CA2333379A1 (en) Lactide-containing polymer and medical material
JP2006307004A (ja) ポリアミノ酸を構成成分とするハイドロゲル
AU2003285286A1 (en) Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol)
BR0015092A (pt) Produtos de polìmero compreendendo composições de copolìmero de polihidróxialcanoato biodegradáveis elásticas e macias e métodos para preparação de tais produtos de polìmeros
US11425907B2 (en) Composition comprising an iodide and a derivative of hyaluronic acid with an oxidative effect, method of preparation thereof and use thereof
EP1150621A4 (de) Methode und zusammensetzung von fluorinierten polymeren zur verhütung von chirurgischen verklebungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0981381

Country of ref document: EP

REN Ceased due to non-payment of the annual fee